🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether QAW039 is safe and has be...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-06
Trial ID
NCT01785602
This was an exploratory, randomized, subject- and investigator-blind, place...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2019-05-21
Trial ID
NCT03810183
This study aims to demonstrate a clinically significant improvement in Forc...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-08
Trial ID
NCT01437735
Treatments Being Tested
This is an exploratory, randomized, subject- and investigator-blinded, plac...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-10-15
Trial ID
NCT03989635
Treatments Being Tested
The aim of the study is to assess whether renal impairment could affect fev...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-07-05
Trial ID
NCT03087942
Treatments Being Tested
A randomized, multicenter, double-blind, placebo- controlled parallel-group...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-11-01
Trial ID
NCT03215758
The purpose of the study was to assess the clinical effect of QAW039 in non...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-05
Trial ID
NCT01836471
Treatments Being Tested
This study will assess the safety and efficacy of QAW039 alone and in combi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01804400
Treatments Being Tested
A Phase 3b Proof-of-Concept study to evaluate the ability of fevipiprant 15...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-03-26
Trial ID
NCT03681093
Treatments Being Tested